1
0
0
News
MAHONING COUNTY COURTS | Vindy Archives
vindyarchives.com
COURTS MAHONING COUNTY Marriage licenses Timothy B. Baker, 30, of 462 Oakridge Drive,
Netzwerk-Profile
Bücher
Annual Reports in Medicinal Chemistry - Google Books
books.google.at
Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging...
Molecular Oncology - Google Books
books.google.at
The genomic era has allowed enormous strides in our understanding of the molecular changes that underlie malignant transformation. Mutations have been...
Molecular Pathology in Drug Discovery and Development - Google Books
books.google.at
Covers powerful new tools for drug development Molecular pathology offers tools and techniques that can greatly enhance the drug discovery and development...
Official Gazette of the United States Patent and Trademark Office:...
books.google.at
... GROWTH FACTOR RECEPTOR ACTIVATING GENE 1 AND RELATED COMPOSITIONS AND METHODS Matthew V . Lorenzi , Philadelphia , Pa . , and Toru ...
Dokumente zum Namen
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor...
www.scienceopen.com
... Dirk Brehmer , Dashyant Dhanak , Matthew V. Lorenzi , Dana Hu-Lowe , Matthew P. Patricelli , Pingda Ren , Yi Liu. Publication date Created: January
Wissenschaftliche Veröffentlichungen
Nerve growth factor regulation of choline acetyltransferase gene...
www.sciencedirect.com
Matthew V. Lorenzi a, Beat Knusel b, Franz Hefti b and William L. Strauss a. ~Department of Molecular and Cellular Pharmacology, University of Miami School of ...
Artikel & Meinungen
Ligand-independent activation of fibroblast growth factor receptor-2...
www.nature.com
Matthew V Lorenzi, Paola Castagnino, Qiong Chen, Marcio Chedid and Toru Miki. Laboratory of Cellular and Molecular Biology, National Cancer Institute, ...
Sonstiges
WO A3 - Combinaisons synergiques de ligands de recepteurs...
patents.google.com
La présente invention concerne des combinaisons chimiothérapiques d'agents cytotoxiques et d'agonistes sélectifs des RARα/β ou des antagonistes de...
Matthew V Lorenzi, Physical Therapy, Canfield OH
www.topnpi.com
Matthew V Lorenzi in Canfield, OH. Matthew V Lorenzi specializes in physical therapy, practices at Boardman-Canfield Road, phone number, opening hours,...
Mr. Matthew V Lorenzi - Cleveland OH, Physical Therapy
www.healthcare6.com
Mr. Matthew V Lorenzi - Cleveland OH, Physical Therapy at Euclid Ave. Phone: (216) View info, ratings, reviews, specialties, ...
AACR Webcasts: From Chemistry to the Clinic: Pathways for Drug...
webcast.aacr.org
Chairperson: Matthew V. Lorenzi, Ph.D. Bristol-Myers Squibb, Princeton, NJ. Free; Not available in mobile view. from Annual Meeting on April 12,
Annual reports in medicinal chemistry , Vol Dialnet
dialnet.unirioja.es
Información de la revista Annual reports in medicinal chemistry
ATP Quito: Matthew Ebden - Paolo Lorenzi live im Ticker - Tennis...
www.eurosport.de
Liveticker zu den Spielen der ATP Quito bei Eurosport: Die komplette Übersicht zu Matthew Ebden - Paolo Lorenzi mit Statistiken, Daten und Infos.
Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer...
www.oncotarget.com
https://doi.org oncotarget Joshua C. Curtin, Matthew V. Lorenzi
Expression of an ATP binding mutant of PKC-δ inhibits sis-induced...
moh-it.pure.elsevier.com
Weiqun Li, Paolo Michieli, Maurizio Alimandi, Matthew V. Lorenzi, Youmei Wu, Lu Hai Wang, Mohammad A. Heidaran, Jacalyn H. Pierce. Istituto Oncologico ...
Homocysteine exerts cell type-specific inhibition of AP-1...
scholars.houstonmethodist.org
Yuichiro J. Suzuki, Matthew V. Lorenzi, Susan Shi, Regina M. Day, Jeffrey B. Blumberg. Academic Institute; •; Research Institute; •; Department of Obstetrics & ...
Identification of a novel series of tetrahydrodibenzazocines as...
www.researchwithrutgers.com
... Derek Norris, Thomas E. Spires, Dan You, Marco M. Gottardis, Matthew V. Lorenzi, Gregory D. Vite. Research output: Contribution to journal › ...
Role of JAK2 Beyond Myeloproliferative Neoplasms (MPNs ...www.intechopen.com › books › ro...
www.intechopen.com
By Theresa M. McDevitt and Matthew V. Lorenzi. Submitted: February 9th 2011Reviewed: August 29th 2011Published: December 14th DOI:
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5- d...
www.osti.gov
The U.S. Department of Energy's Office of Scientific and Technical Information
Neu differentiation factor/heregulin induction by hepatocyte and...
go.gale.com
Gale OneFile includes Neu differentiation factor/heregulin induction by hepat by Paola Castagnino, Matthew V Lorenzi, Ju. Click to explore.
Selective retinoids and rexinoids in cancer therapy and...
pubmed.ncbi.nlm.nih.gov
Natural and synthetic retinoids are effective inhibitors of tumor cell growth in vitro and in vivo. However, the toxicity of natural derivatives of vitamin A...
The Combined Effect of FGFR Inhibition and PD-1 Blockade ...read.qxmd.com › read › the-combi...
read.qxmd.com
... T Kirschmeier, Kathryn Packman, Pasi A Janne, Christopher Moy, Kwok-Kin Wong, Raluca I Verona, Matthew V Lorenzi. Cancer Immunology Research 2019, ...
Verwandte Suchanfragen zu Matthew V. Lorenzi
|
Personen Vorname "Matthew" (7985) Name "Lorenzi" (182) |
sortiert nach Relevanz / Datum